Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : VTRS crawled time : 13:00 save search
Revance to Present New DAXXIFY® Data at the American Academy of Neurology 2024 Annual Meeting
Published: 2024-04-12 (Crawled : 13:00) - biospace.com/
VTRS | $11.25 1.17% 1.16% 4.7M
|
Health Technology
|
| O: -0.17%
H: 0.17%
C: -1.9%
RVNC | $3.77 -0.53% -0.53% 1.6M
|
Health Technology
|
| O: -2.01%
H: 1.37%
C: -5.92%
daxxify neurology meeting
Revance to Release Third Quarter 2023 Financial Results on Wednesday, November 8, 2023
Published: 2023-11-01 (Crawled : 13:00) - biospace.com/
VTRS | $11.25 1.17% 1.16% 4.7M
|
Health Technology
|
| O: -0.45%
H: 0.96%
C: 0.68%
RVNC | $3.77 -0.53% -0.53% 1.6M
|
Health Technology
|
| O: -0.63%
H: 1.66%
C: 1.15%
financial results
Viatris and Ocuphire Pharma Announce FDA Approval of RYZUMVl™ (Phentolamine Ophthalmic Solution)
Published: 2023-09-27 (Crawled : 13:00) - biospace.com/
VTRS | $11.25 1.17% 1.16% 4.7M
|
Health Technology
|
| O: 0.0%
H: 1.03%
C: -1.34%
OCUP | $1.66 -0.6% -0.6% 230K
|
Health Technology
|
| O: 0.75%
H: 3.46%
C: -6.67%
fda pharma approval ryzumvl
U.S. FDA Approves First Therapeutic Indication for Revance’s DAXXIFY® (DaxibotulinumtoxinA-lanm) for Injection for the Treatment of Cervical Dystonia
Published: 2023-08-14 (Crawled : 13:00) - biospace.com/
VTRS | $11.25 1.17% 1.16% 4.7M
|
Health Technology
|
| O: -0.35%
H: 0.0%
C: -1.06%
RVNC | $3.77 -0.53% -0.53% 1.6M
|
Health Technology
|
| O: 6.13%
H: 1.54%
C: -3.04%
daxxify fda treatment injection
Revance to Release Second Quarter 2023 Financial Results on Tuesday, August 8, 2023
Published: 2023-08-01 (Crawled : 13:00) - biospace.com/
VTRS | $11.25 1.17% 1.16% 4.7M
|
Health Technology
|
| O: -0.19%
H: 0.29%
C: -2.76%
RVNC | $3.77 -0.53% -0.53% 1.6M
|
Health Technology
|
| O: -1.1%
H: 0.0%
C: 0.0%
financial results
Aerosol Propellant Market size to grow by USD 3,668.05 million from 2022 to 2027: Rapid growth of the personal care industry to be a key driver - Technavio
Published: 2023-06-21 (Crawled : 13:00) - prnewswire.com
VTRS | $11.25 1.17% 1.16% 4.7M
|
Health Technology
|
| O: -0.1%
H: 0.15%
C: -0.69%
LIN | News | $446.32 -0.03% -0.02% 1.7M
|
Process Industries
|
| O: -0.41%
H: 1.33%
C: 0.95%
HON | News M | $194.27 1.67% 1.64% 3.6M
|
Producer Manufacturing
|
| O: -0.55%
H: 1.75%
C: 1.26%
rapid care growth market
VTRS Investors Have Opportunity to Lead Viatris Inc. Securities Fraud Lawsuit
Published: 2023-06-05 (Crawled : 13:00) - prnewswire.com
VTRS | $11.25 1.17% 1.16% 4.7M
|
Health Technology
|
| O: 0.54%
H: 0.0%
C: -0.53%
LPSN | $0.5099 -8.57% -9.37% 4.4M
|
Technology Services
|
| O: -6.4%
H: 1.42%
C: -1.42%
HBNC | $11.85 3.77% 3.63% 230K
|
Finance
|
| O: 0.1%
H: 0.1%
C: -2.84%
Robert J. Coury to Transition from Executive Chairman of Viatris to Chairman Emeritus and Senior Strategic Advisor to the Board and Management at the End of the Year
Published: 2023-05-22 (Crawled : 13:00) - biospace.com/
VTRS | $11.25 1.17% 1.16% 4.7M
|
Health Technology
|
| O: 1.93%
H: 1.68%
C: -0.42%
management year
Outlook on the Pharmaceutical Drugs Global Market to 2027: Look at the Changing Structure of the Pharma and Healthcare Industry
Published: 2023-01-03 (Crawled : 13:00) - prnewswire.com
ENDPQ | $0.0006 -50.0% 3.4K
|
n/a
|
| O: -1.13%
H: 28.57%
C: 19.0%
CSLLY | $86.918 3.3% 60K
|
n/a
|
| O: -3.93%
H: 2.17%
C: 1.75%
MNK | $0.3402 -0.06% 540K
|
n/a
|
| O: 3.1%
H: 0.0%
C: -2.75%
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: -0.2%
H: 2.06%
C: 2.06%
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 1.09%
H: 0.54%
C: 0.54%
UCBJY | $63.676 -4.38% 7.2K
|
Manufacturing
|
| O: 1.0%
H: 0.0%
C: -0.26%
ALPMY | $9.47 -1.11% 520K
|
Manufacturing
|
| O: 3.43%
H: 0.0%
C: -2.93%
VTRS | $11.25 1.17% 1.16% 4.7M
|
Health Technology
|
| O: 0.54%
H: 2.5%
C: 1.7%
NVO | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: 1.43%
H: 0.84%
C: -0.23%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.42%
H: 1.35%
C: 1.22%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.28%
H: 1.26%
C: 1.15%
GSK | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: -0.57%
H: 1.35%
C: 1.0%
BHC | $8.69 1.05% 0.0% 2.9M
|
Health Technology
|
| O: 0.48%
H: 3.96%
C: -0.48%
ABBV | News | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 0.27%
H: 0.6%
C: 0.21%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.16%
H: 0.0%
C: 0.0%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: -0.67%
H: 0.66%
C: 0.3%
pharma global market
Viatris Reports Strong Third Quarter 2022 Results
Published: 2022-11-07 (Crawled : 13:00) - biospace.com/
VTRS | $11.25 1.17% 1.16% 4.7M
|
Health Technology
|
| O: 6.6%
H: 10.54%
C: 6.09%
results
Revance to Release Third Quarter 2022 Financial Results on Tuesday, November 8, 2022
Published: 2022-11-01 (Crawled : 13:00) - biospace.com/
VTRS | $11.25 1.17% 1.16% 4.7M
|
Health Technology
|
| O: 0.59%
H: 1.18%
C: 0.59%
RVNC | $3.77 -0.53% -0.53% 1.6M
|
Health Technology
|
| O: 0.85%
H: 1.73%
C: -0.18%
financial results
Revance Submits Supplemental Biologics License Application (sBLA) for DAXXIFY™ (DaxibotulinumtoxinA-lanm) for Injection for the Treatment of Cervical Dystonia
Published: 2022-10-20 (Crawled : 13:00) - biospace.com/
VTRS | $11.25 1.17% 1.16% 4.7M
|
Health Technology
|
| O: 0.11%
H: 1.17%
C: -0.53%
RVNC | $3.77 -0.53% -0.53% 1.6M
|
Health Technology
|
| O: -0.04%
H: 3.56%
C: -1.55%
treatment application license injection
Revance to Present Clinical Data on the Efficacy and Safety Profile of DAXXIFY™ (DaxibotulinumtoxinA-lanm) for Injection at the 2022 American Society for Dermatologic Surgery (ASDS) Annual Meeting
Published: 2022-10-10 (Crawled : 13:00) - biospace.com/
VTRS | $11.25 1.17% 1.16% 4.7M
|
Health Technology
|
| O: 0.92%
H: 0.57%
C: -0.79%
RVNC | $3.77 -0.53% -0.53% 1.6M
|
Health Technology
|
| O: -0.27%
H: 0.0%
C: -1.37%
meeting injection lsd
Mapi Pharma Announces Positive Top-Line Results from GA Depot Phase III Trial for Relapsing forms of Multiple Sclerosis (RMS)
Published: 2022-09-21 (Crawled : 13:00) - biospace.com/
VTRS | $11.25 1.17% 1.16% 4.7M
|
Health Technology
|
| O: 1.66%
H: 2.88%
C: -1.63%
pharma trial positive sclerosis multiple sclerosis
Revance Announces Two Publications Highlighting the Efficacy and Safety Profile of DAXXIFY™ (DaxibotulinumtoxinA-lanm) For Injection in the Aesthetic Surgery Journal
Published: 2022-09-19 (Crawled : 13:00) - biospace.com/
VTRS | $11.25 1.17% 1.16% 4.7M
|
Health Technology
|
| O: -0.86%
H: 1.25%
C: 0.76%
RVNC | $3.77 -0.53% -0.53% 1.6M
|
Health Technology
|
| O: -0.81%
H: 3.61%
C: 3.42%
aesthetic injection
Viatris and Biocon Biologics Announce Launch of Interchangeable SEMGLEE® (insulin glargine-yfgn) Injection and Insulin Glargine (insulin glargine-yfgn) Injection
Published: 2021-11-16 (Crawled : 13:00) - biospace.com/
VTRS | $11.25 1.17% 1.16% 4.7M
|
Health Technology
|
| O: -0.99%
H: 0.14%
C: -0.64%
injection insulin glargine
PFIZER REPORTS THIRD-QUARTER 2021 RESULTS
Published: 2021-11-02 (Crawled : 13:00) - biospace.com/
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: 1.14%
H: 0.94%
C: -1.98%
ALPMY | $9.47 -1.11% 520K
|
Manufacturing
|
| O: -1.58%
H: 0.42%
C: 0.24%
VTRS | $11.25 1.17% 1.16% 4.7M
|
Health Technology
|
| O: 3.46%
H: 0.7%
C: -0.09%
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: 2.06%
H: 0.0%
C: 0.0%
GSK | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: 1.16%
H: 0.75%
C: -0.19%
LLY | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -1.55%
H: 0.0%
C: 0.0%
BNTX | $86.82 0.75% 0.75% 1.6M
|
Health Technology
|
| O: 0.13%
H: 3.09%
C: 2.62%
ARVN | $34.78 1.43% 1.41% 940K
|
Health Technology
|
| O: 1.4%
H: 4.09%
C: 4.07%
results
Viatris Inc. to Release Third Quarter 2021 Financial Results on Nov. 8, 2021
Published: 2021-10-13 (Crawled : 13:00) - biospace.com/
VTRS | $11.25 1.17% 1.16% 4.7M
|
Health Technology
|
| O: -0.07%
H: 0.82%
C: -0.59%
financial results results
Viatris Inc. to Participate in Citi's 16th Annual BioPharma Conference
Published: 2021-08-30 (Crawled : 13:00) - biospace.com/
VTRS | $11.25 1.17% 1.16% 4.7M
|
Health Technology
|
| O: -0.03%
H: 1.33%
C: 0.56%
biopharma conference
Viatris Inc. to Participate in BofA Global Healthcare Conference
Published: 2021-08-30 (Crawled : 13:00) - biospace.com/
VTRS | $11.25 1.17% 1.16% 4.7M
|
Health Technology
|
| O: -0.03%
H: 1.33%
C: 0.56%
conference
Gainers vs Losers
| 69% | 31% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
KNW 4 | $0.59 -0.71% 18.64% 27K
|
Manufacturing
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | News | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.